HMGB3 and ovarian carcinoma: Next, to confirm whether HMGB3 activates the MAPK signaling pathway in ovarian cancer, western blot was used to examine the phosphorylation levels of p-MEK1/2 and p-ERK1/2, which are key factors in the MAPK/ERK pathway.